Insulin glargine vs rosiglitazone as add-on therapy in patients failing sulfonylurea and metformin combination therapy.

Trial Profile

Insulin glargine vs rosiglitazone as add-on therapy in patients failing sulfonylurea and metformin combination therapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jul 2009

At a glance

  • Drugs Insulin glargine (Primary) ; Rosiglitazone
  • Indications Diabetes mellitus; Obesity; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Aventis Pharmaceuticals
  • Most Recent Events

    • 07 Jul 2009 Actual initiation date changed from Sep 2002 to Jun 2002 as reported by ClinicalTrials.gov.
    • 14 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top